PDB Short entry for 1OPT
HEADER    PROTEIN BINDING/VIRUS/VIRAL PROTEIN/    06-MAR-03   1OPT              
TITLE     THEORETICAL MODEL OF CCR5 RECEPTOR IN COMPLEX WITH HIV                
TITLE    2 GP120 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR                         
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: C-C CHEMOKINE RECEPTOR TYPE 5;                             
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: CCR5;                                                       
COMPND   5 MOL_ID: 2;                                                           
COMPND   6 MOLECULE: EXTERIOR MEMBRANE GLYCOPROTEIN;                            
COMPND   7 CHAIN: G;                                                            
COMPND   8 FRAGMENT: CORE;                                                      
COMPND   9 SYNONYM: ENVELOPE GLYCOPROTEIN GP120;                                
COMPND  10 MUTATION: YES;                                                       
COMPND  11 MOL_ID: 3;                                                           
COMPND  12 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD4;                           
COMPND  13 CHAIN: C;                                                            
COMPND  14 FRAGMENT: D1D2, N-TERMINAL TWO DOMAIN FRAGMENT                       
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 MOL_ID: 2;                                                           
SOURCE   5 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1;            
SOURCE   6 ORGANISM_COMMON: HIV-1;                                              
SOURCE   7 MOL_ID: 3;                                                           
SOURCE   8 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   9 ORGANISM_COMMON: HUMAN                                               
KEYWDS    GLYCOPROTEIN, G-PROTEIN COUPLED RECEPTOR, COMPLEX (HIV                
KEYWDS   2 ENVELOPE PROTEIN/CD4/CCR5)                                           
EXPDTA    THEORETICAL MODEL                                                     
AUTHOR    S.Q.LIU,X.F.SHI,Z.R.SUN                                               
REVDAT   1   25-MAR-03 1OPT    0                                                
JRNL        AUTH   S.Q.LIU,X.F.SHI,Z.R.SUN                                      
JRNL        TITL   STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF                
JRNL        TITL 2 HUMAN CCR5 RECEPTOR IN COMPLEX WITH HIV GP120                
JRNL        TITL 3 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR BY                    
JRNL        TITL 4 MOLECULAR MODELING STUDIES                                   
JRNL        REF    TO BE PUBLISHED                                              
JRNL        REFN                                                                
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.Q.LIU,X.F.SHI,Z.R.SUN                                      
REMARK   1  TITL   CHARACTERIZE DYNAMIC CONFORMATIONAL SPACE OF HUMAN           
REMARK   1  TITL 2 CCR5 EXTRACELLULAR DOMAIN BY MOLECULAR MODELING              
REMARK   1  TITL 3 AND MOLECULAR DYNAMICS SIMULATION                            
REMARK   1  REF    TO BE PUBLISHED                                              
REMARK   1  REFN                                                                
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : INSIGHT II 2002                                      
REMARK   3   AUTHORS     : NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1OPT COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998                       
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-MAR-2003.                
REMARK 100 THE RCSB ID CODE IS RCSB018542.                                      
REMARK 220                                                                      
REMARK 220 EXPERIMENTAL DETAILS                                                 
REMARK 220  EXPERIMENT TYPE                : THEORETICAL MODELLING              
REMARK 220                                                                      
REMARK 220 REMARK: THIS MODEL INDICATES THAT THE ECL2 OF CCR5 BEGINS TO         
REMARK 220         INTERACT WITH V3 LOOP BASE OF GP120, IT IS A SNAPSHOT OF     
REMARK 220         THE TRANSITION STATE OF THE BINDING OF CCR5 TO GP120.        
REMARK 220         THIS STRUCTURE WAS BUILT USING APPROACHES OF HOMOLOGY        
REMARK 220         MODELING AND DOCKING. THE STRUCTURES OF THE                  
REMARK 220         TRANSMEMBRANE HELICES OF CCR5 WERE FIXED AND THE             
REMARK 220         CONFORMATION OF GP120-CD4 WAS TETHERED DURING MOLECULAR      
REMARK 220         DYNAMICS SIMULATION AND DOCKING.                             
REMARK 225                                                                      
REMARK 225 THEORETICAL MODEL                                                    
REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE.           
REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND                
REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE                   
REMARK 225 RECORDS ARE MEANINGLESS.                                             
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     SER G   398                                                      
REMARK 465     THR G   399                                                      
REMARK 465     TRP G   400                                                      
REMARK 465     SER G   401                                                      
REMARK 465     THR G   402                                                      
REMARK 465     GLU G   403                                                      
REMARK 465     GLY G   404                                                      
REMARK 465     SER G   405                                                      
REMARK 465     ASN G   406                                                      
REMARK 465     ASN G   407                                                      
REMARK 465     THR G   408                                                      
REMARK 465     GLU G   409                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  11       98.37    148.71                                   
REMARK 500    LYS A  59      -62.34     75.66                                   
REMARK 500    VAL A 199      -85.29     78.40                                   
REMARK 500    ARG A 225      -61.14     64.48                                   
REMARK 500    ASN A 226      -59.50     75.53                                   
REMARK 500    ARG A 235      -66.79     75.51                                   
REMARK 500    GLN A 261      -70.02     64.07                                   
REMARK 500    PHE A 264      -62.24     68.84                                   
REMARK 500    ASP A 276      -63.06     84.52                                   
REMARK 500    TYR A 307      -73.36     80.33                                   
REMARK 500    GLN A 328      -85.99     59.57                                   
REMARK 500    SER A 336      -72.03     71.23                                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 MET A    1    ASP A    2                  148.03                     
REMARK 500 ILE A    9    TYR A   10                 -146.53                     
REMARK 500 CYS A   20    GLN A   21                  139.63                     
REMARK 500 LYS A   22    ILE A   23                  135.72                     
REMARK 500 ALA A   30    ARG A   31                 -147.70                     
REMARK 500 MET A  100    CYS A  101                  -82.98                     
REMARK 500 THR A  167    ARG A  168                 -149.45                     
REMARK 500 PHE A  182    PRO A  183                  143.18                     
REMARK 500 ILE A  198    VAL A  199                  132.00                     
REMARK 500 PHE A  260    GLN A  261                  141.72                     
REMARK 500 LEU A  266    ASN A  267                 -143.07                     
REMARK 500 LEU A  275    ASP A  276                  138.04                     
REMARK 500 GLN A  277    ALA A  278                 -105.86                     
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1G9M   RELATED DB: PDB                                   
REMARK 900 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4           
REMARK 900 AND INDUCED NEUTRALIZING ANTIBODY 17B                                
REMARK 900 RELATED ID: 1ND8   RELATED DB: PDB                                   
REMARK 900 THEORETICAL MODEL OF HUMAN CCR5 WITH DISULFIDE BOND BETWEEN          
REMARK 900 CYS20 AND CYS269, THE N-TERMINUS 1-19 REGION OF THIS                 
REMARK 900 STRUCTURE EXTENDS INTO THE OUTER SPACE OF THE DOMAIN FORMED          
REMARK 900 BY EXTRACELLULAR LOOP1-3.                                            
REMARK 900 RELATED ID: 1OPN   RELATED DB: PDB                                   
REMARK 900 THE NT OF CCR5 RECOGNIZES AND BINDS TO BRIDGING SHEET OF             
REMARK 900 GP120                                                                
REMARK 900 RELATED ID: 1OPW   RELATED DB: PDB                                   
REMARK 900 CCR5 FULLY INTERACTS WITH GP120                                      
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 IN CHAIN G, GLY 128, ALA 129 AND GLY 194 SUBSTITUTE                  
REMARK 999 FOR THE V1/V2 LOOP (128-194), GLY 298, ALA 299 AND                   
REMARK 999 GLY 329 SUBSTITUTE FOR V3 LOOP (298-329).                            
DBREF  1OPT A    1   352  UNP    P51681   CKR5_HUMAN       1    352             
DBREF  1OPT G   83   127  UNP    P04578   ENV_HV1H2       83    127             
DBREF  1OPT G  195   297  UNP    P04578   ENV_HV1H2      195    297             
DBREF  1OPT G  330   492  UNP    P04578   ENV_HV1H2      330    492             
DBREF  1OPT C    1   181  UNP    P01730   CD4_HUMAN       26    206             
SEQADV 1OPT GLY G  128  UNP  P04578              SEE REMARK 999                 
SEQADV 1OPT ALA G  129  UNP  P04578              SEE REMARK 999                 
SEQADV 1OPT GLY G  194  UNP  P04578              SEE REMARK 999                 
SEQADV 1OPT GLY G  298  UNP  P04578              SEE REMARK 999                 
SEQADV 1OPT ALA G  299  UNP  P04578              SEE REMARK 999                 
SEQADV 1OPT GLY G  329  UNP  P04578              SEE REMARK 999                 
SEQRES   1 A  352  MET ASP TYR GLN VAL SER SER PRO ILE TYR ASP ILE ASN          
SEQRES   2 A  352  TYR TYR THR SER GLU PRO CYS GLN LYS ILE ASN VAL LYS          
SEQRES   3 A  352  GLN ILE ALA ALA ARG LEU LEU PRO PRO LEU TYR SER LEU          
SEQRES   4 A  352  VAL PHE ILE PHE GLY PHE VAL GLY ASN MET LEU VAL ILE          
SEQRES   5 A  352  LEU ILE LEU ILE ASN CYS LYS ARG LEU LYS SER MET THR          
SEQRES   6 A  352  ASP ILE TYR LEU LEU ASN LEU ALA ILE SER ASP LEU PHE          
SEQRES   7 A  352  PHE LEU LEU THR VAL PRO PHE TRP ALA HIS TYR ALA ALA          
SEQRES   8 A  352  ALA GLN TRP ASP PHE GLY ASN THR MET CYS GLN LEU LEU          
SEQRES   9 A  352  THR GLY LEU TYR PHE ILE GLY PHE PHE SER GLY ILE PHE          
SEQRES  10 A  352  PHE ILE ILE LEU LEU THR ILE ASP ARG TYR LEU ALA VAL          
SEQRES  11 A  352  VAL HIS ALA VAL PHE ALA LEU LYS ALA ARG THR VAL THR          
SEQRES  12 A  352  PHE GLY VAL VAL THR SER VAL ILE THR TRP VAL VAL ALA          
SEQRES  13 A  352  VAL PHE ALA SER LEU PRO GLY ILE ILE PHE THR ARG SER          
SEQRES  14 A  352  GLN LYS GLU GLY LEU HIS TYR THR CYS SER SER HIS PHE          
SEQRES  15 A  352  PRO TYR SER GLN TYR GLN PHE TRP LYS ASN PHE GLN THR          
SEQRES  16 A  352  LEU LYS ILE VAL ILE LEU GLY LEU VAL LEU PRO LEU LEU          
SEQRES  17 A  352  VAL MET VAL ILE CYS TYR SER GLY ILE LEU LYS THR LEU          
SEQRES  18 A  352  LEU ARG CYS ARG ASN GLU LYS LYS ARG HIS ARG ALA VAL          
SEQRES  19 A  352  ARG LEU ILE PHE THR ILE MET ILE VAL TYR PHE LEU PHE          
SEQRES  20 A  352  TRP ALA PRO TYR ASN ILE VAL LEU LEU LEU ASN THR PHE          
SEQRES  21 A  352  GLN GLU PHE PHE GLY LEU ASN ASN CYS SER SER SER ASN          
SEQRES  22 A  352  ARG LEU ASP GLN ALA MET GLN VAL THR GLU THR LEU GLY          
SEQRES  23 A  352  MET THR HIS CYS CYS ILE ASN PRO ILE ILE TYR ALA PHE          
SEQRES  24 A  352  VAL GLY GLU LYS PHE ARG ASN TYR LEU LEU VAL PHE PHE          
SEQRES  25 A  352  GLN LYS HIS ILE ALA LYS ARG PHE CYS LYS CYS CYS SER          
SEQRES  26 A  352  ILE PHE GLN GLN GLU ALA PRO GLU ARG ALA SER SER VAL          
SEQRES  27 A  352  TYR THR ARG SER THR GLY GLU GLN GLU ILE SER VAL GLY          
SEQRES  28 A  352  LEU                                                          
SEQRES   1 G  317  GLU VAL VAL LEU VAL ASN VAL THR GLU ASN PHE ASN MET          
SEQRES   2 G  317  TRP LYS ASN ASP MET VAL GLU GLN MET HIS GLU ASP ILE          
SEQRES   3 G  317  ILE SER LEU TRP ASP GLN SER LEU LYS PRO CYS VAL LYS          
SEQRES   4 G  317  LEU THR PRO LEU CYS VAL GLY ALA GLY SER CYS ASN THR          
SEQRES   5 G  317  SER VAL ILE THR GLN ALA CYS PRO LYS VAL SER PHE GLU          
SEQRES   6 G  317  PRO ILE PRO ILE HIS TYR CYS ALA PRO ALA GLY PHE ALA          
SEQRES   7 G  317  ILE LEU LYS CYS ASN ASN LYS THR PHE ASN GLY THR GLY          
SEQRES   8 G  317  PRO CYS THR ASN VAL SER THR VAL GLN CYS THR HIS GLY          
SEQRES   9 G  317  ILE ARG PRO VAL VAL SER THR GLN LEU LEU LEU ASN GLY          
SEQRES  10 G  317  SER LEU ALA GLU GLU GLU VAL VAL ILE ARG SER VAL ASN          
SEQRES  11 G  317  PHE THR ASP ASN ALA LYS THR ILE ILE VAL GLN LEU ASN          
SEQRES  12 G  317  THR SER VAL GLU ILE ASN CYS THR GLY ALA GLY HIS CYS          
SEQRES  13 G  317  ASN ILE SER ARG ALA LYS TRP ASN ASN THR LEU LYS GLN          
SEQRES  14 G  317  ILE ALA SER LYS LEU ARG GLU GLN PHE GLY ASN ASN LYS          
SEQRES  15 G  317  THR ILE ILE PHE LYS GLN SER SER GLY GLY ASP PRO GLU          
SEQRES  16 G  317  ILE VAL THR HIS SER PHE ASN CYS GLY GLY GLU PHE PHE          
SEQRES  17 G  317  TYR CYS ASN SER THR GLN LEU PHE ASN SER THR TRP PHE          
SEQRES  18 G  317  ASN SER THR TRP SER THR GLU GLY SER ASN ASN THR GLU          
SEQRES  19 G  317  GLY SER ASP THR ILE THR LEU PRO CYS ARG ILE LYS GLN          
SEQRES  20 G  317  ILE ILE ASN MET TRP GLN LYS VAL GLY LYS ALA MET TYR          
SEQRES  21 G  317  ALA PRO PRO ILE SER GLY GLN ILE ARG CYS SER SER ASN          
SEQRES  22 G  317  ILE THR GLY LEU LEU LEU THR ARG ASP GLY GLY ASN SER          
SEQRES  23 G  317  ASN ASN GLU SER GLU ILE PHE ARG PRO GLY GLY GLY ASP          
SEQRES  24 G  317  MET ARG ASP ASN TRP ARG SER GLU LEU TYR LYS TYR LYS          
SEQRES  25 G  317  VAL VAL LYS ILE GLU                                          
SEQRES   1 C  181  LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL GLU          
SEQRES   2 C  181  LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN PHE          
SEQRES   3 C  181  HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY ASN          
SEQRES   4 C  181  GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU ASN          
SEQRES   5 C  181  ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN GLY          
SEQRES   6 C  181  ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU ASP          
SEQRES   7 C  181  SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS GLU          
SEQRES   8 C  181  GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SER          
SEQRES   9 C  181  ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU THR          
SEQRES  10 C  181  LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN CYS          
SEQRES  11 C  181  ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS THR          
SEQRES  12 C  181  LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY THR          
SEQRES  13 C  181  TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL GLU          
SEQRES  14 C  181  PHE LYS ILE ASP ILE VAL VAL LEU ALA PHE GLN LYS              
HELIX    1   1 LEU A   32  CYS A   58  1                                  27    
HELIX    2   2 TYR A   68  VAL A   83  1                                  16    
HELIX    3   3 VAL A   83  ALA A   91  1                                   9    
HELIX    4   4 LEU A  103  PHE A  109  1                                   7    
HELIX    5   5 ILE A  110  ILE A  124  1                                  15    
HELIX    6   6 ILE A  151  LEU A  161  1                                  11    
HELIX    7   7 VAL A  199  LEU A  205  1                                   7    
HELIX    8   8 LEU A  207  ILE A  217  1                                  11    
HELIX    9   9 ARG A  235  PHE A  260  1                                  26    
HELIX   10  10 ALA A  278  MET A  287  1                                  10    
HELIX   11  11 THR A  288  CYS A  290  5                                   3    
HELIX   12  12 CYS A  291  VAL A  300  1                                  10    
HELIX   13  13 ASN G   98  GLN G  114  1                                  17    
HELIX   14  14 ARG G  335  PHE G  353  1                                  19    
HELIX   15  15 ASP G  368  THR G  373  1                                   6    
HELIX   16  16 SER G  387  PHE G  391  5                                   5    
HELIX   17  17 ASP G  474  TYR G  484  1                                  11    
HELIX   18  18 LEU C   51  ASP C   53  5                                   3    
HELIX   19  19 ARG C   58  GLY C   65  5                                   8    
HELIX   20  20 LYS C   75  SER C   79  5                                   5    
HELIX   21  21 GLU C  150  SER C  154  5                                   5    
SHEET    1   A 4 VAL G  84  PHE G  93  0                                        
SHEET    2   A 4 GLY G 237  VAL G 245 -1  O  GLY G 237   N  PHE G  93           
SHEET    3   A 4 PHE G 223  CYS G 228 -1  O  ILE G 225   N  VAL G 245           
SHEET    4   A 4 TYR G 486  LYS G 490 -1  O  LYS G 487   N  LEU G 226           
SHEET    1   B 4 SER G 199  ILE G 201  0                                        
SHEET    2   B 4 VAL G 120  THR G 123 -1  O  LYS G 121   N  ILE G 201           
SHEET    3   B 4 LYS G 432  MET G 434 -1  O  LYS G 432   N  LEU G 122           
SHEET    4   B 4 ILE G 423  ASN G 425 -1  N  ILE G 424   O  ALA G 433           
SHEET    1   C11 SER G 393  TRP G 395  0                                        
SHEET    2   C11 ILE G 359  PHE G 361 -1  O  ILE G 359   N  TRP G 395           
SHEET    3   C11 GLU G 466  PRO G 470  1  O  GLU G 466   N  ILE G 360           
SHEET    4   C11 ARG G 444  ARG G 456 -1  O  THR G 455   N  ARG G 469           
SHEET    5   C11 LEU G 260  LEU G 261 -1  O  LEU G 260   N  THR G 450           
SHEET    6   C11 ARG G 444  ARG G 456 -1  N  THR G 450   O  LEU G 260           
SHEET    7   C11 ILE G 284  THR G 297 -1  N  ILE G 284   O  LEU G 454           
SHEET    8   C11 VAL G 271  ARG G 273 -1  O  VAL G 271   N  GLN G 287           
SHEET    9   C11 ILE G 284  THR G 297 -1  N  ILE G 285   O  ARG G 273           
SHEET   10   C11 HIS G 330  SER G 334 -1  O  HIS G 330   N  THR G 297           
SHEET   11   C11 THR G 413  PRO G 417 -1  N  ILE G 414   O  ILE G 333           
SHEET    1   D 3 HIS G 374  CYS G 378  0                                        
SHEET    2   D 3 GLU G 381  CYS G 385 -1  N  GLU G 381   O  CYS G 378           
SHEET    3   D 3 ILE G 420  LYS G 421 -1  N  LYS G 421   O  PHE G 382           
SHEET    1   E 9 PHE C  43  LYS C  46  0                                        
SHEET    2   E 9 LYS C  35  GLN C  40 -1  O  GLY C  38   N  THR C  45           
SHEET    3   E 9 PHE C  26  LYS C  29 -1  O  PHE C  26   N  ASN C  39           
SHEET    4   E 9 THR C  81  VAL C  86 -1  N  ILE C  83   O  LYS C  29           
SHEET    5   E 9 GLU C  91  ALA C 102 -1  N  GLU C  91   O  CYS C  84           
SHEET    6   E 9 VAL C   3  LYS C   7  1  N  VAL C   4   O  GLN C  94           
SHEET    7   E 9 GLU C  91  ALA C 102  1  O  GLN C  94   N  VAL C   4           
SHEET    8   E 9 LEU C 114  GLU C 119 -1  N  THR C 117   O  THR C 101           
SHEET    9   E 9 THR C 143  VAL C 146 -1  O  LEU C 144   N  LEU C 116           
SHEET    1   F 3 VAL C  12  LEU C  14  0                                        
SHEET    2   F 3 LEU C  69  ILE C  71 -1  N  LEU C  69   O  LEU C  14           
SHEET    3   F 3 ALA C  55  ASP C  56 -1  O  ASP C  56   N  ILE C  70           
SHEET    1   G 5 HIS C 107  LEU C 109  0                                        
SHEET    2   G 5 LYS C 166  LEU C 177  1  O  VAL C 175   N  LEU C 108           
SHEET    3   G 5 GLY C 155  GLN C 163 -1  N  GLY C 155   O  ILE C 174           
SHEET    4   G 5 SER C 127  ARG C 131 -1  N  SER C 127   O  LEU C 162           
SHEET    5   G 5 ASN C 137  GLY C 140 -1  N  ILE C 138   O  CYS C 130           
SSBOND   1 CYS A   20    CYS A  269                                             
SSBOND   2 CYS A  101    CYS A  178                                             
SSBOND   3 CYS G  119    CYS G  205                                             
SSBOND   4 CYS G  126    CYS G  196                                             
SSBOND   5 CYS G  218    CYS G  247                                             
SSBOND   6 CYS G  228    CYS G  239                                             
SSBOND   7 CYS G  296    CYS G  331                                             
SSBOND   8 CYS G  378    CYS G  445                                             
SSBOND   9 CYS G  385    CYS G  418                                             
SSBOND  10 CYS C   16    CYS C   84                                             
SSBOND  11 CYS C  130    CYS C  159                                             
CISPEP   1 TYR A    3    GLN A    4          0        12.85                     
CISPEP   2 ASP A   11    ILE A   12          0       -20.46                     
CISPEP   3 SER A   17    GLU A   18          0         3.93                     
CISPEP   4 PRO A   19    CYS A   20          0        10.26                     
CISPEP   5 ALA A   92    GLN A   93          0        -7.25                     
CISPEP   6 GLN A   93    TRP A   94          0        -2.01                     
CISPEP   7 PHE A   96    GLY A   97          0        -1.92                     
CISPEP   8 CYS A  101    GLN A  102          0        -1.48                     
CISPEP   9 TYR A  127    LEU A  128          0         1.53                     
CISPEP  10 ALA A  129    VAL A  130          0         4.55                     
CISPEP  11 PHE A  144    GLY A  145          0        -8.34                     
CISPEP  12 PHE A  166    THR A  167          0       -18.88                     
CISPEP  13 GLU A  172    GLY A  173          0        -0.25                     
CISPEP  14 GLN A  186    TYR A  187          0        -9.13                     
CISPEP  15 ARG A  223    CYS A  224          0       -12.89                     
CISPEP  16 ASN A  268    CYS A  269          0         0.72                     
CISPEP  17 GLY A  301    GLU A  302          0         3.76                     
CISPEP  18 ALA A  317    LYS A  318          0        -7.97                     
CISPEP  19 ALA A  331    PRO A  332          0         5.02                     
CISPEP  20 VAL A  338    TYR A  339          0        18.79                     
CISPEP  21 VAL A  350    GLY A  351          0        11.38                     
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000